These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20130206)

  • 21. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency?
    Pons F; Robert A; Marini JF; Léger JJ
    J Neurol Sci; 1994 Apr; 122(2):162-70. PubMed ID: 8021701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
    Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
    Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
    Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
    Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
    Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
    Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.
    Janssen PM; Hiranandani N; Mays TA; Rafael-Fortney JA
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2373-8. PubMed ID: 16024571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac and Skeletal Muscle Pathology in the D2/mdx Mouse Model and Caveats Associated with the Quantification of Utrophin.
    Kennedy TL; Dugdale HF
    Methods Mol Biol; 2023; 2587():55-66. PubMed ID: 36401024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
    Tinsley JM; Fairclough RJ; Storer R; Wilkes FJ; Potter AC; Squire SE; Powell DS; Cozzoli A; Capogrosso RF; Lambert A; Wilson FX; Wren SP; De Luca A; Davies KE
    PLoS One; 2011 May; 6(5):e19189. PubMed ID: 21573153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
    Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
    Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
    Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
    Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
    Berry SE; Liu J; Chaney EJ; Kaufman SJ
    Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.
    Mu X; Usas A; Tang Y; Lu A; Wang B; Weiss K; Huard J
    FASEB J; 2013 Sep; 27(9):3619-31. PubMed ID: 23704088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal nitric oxide synthase localizes to utrophin expressing intercalated discs and stabilizes their structural integrity.
    Gonzalez JP; Crassous PA; Schneider JS; Beuve A; Fraidenraich D
    Neuromuscul Disord; 2015 Dec; 25(12):964-76. PubMed ID: 26483274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy.
    Dowling P; Culligan K; Ohlendieck K
    Naturwissenschaften; 2002 Feb; 89(2):75-8. PubMed ID: 12046625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice.
    Li D; Yue Y; Duan D
    PLoS One; 2010 Dec; 5(12):e15286. PubMed ID: 21187970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.